HK45193A - Ozone decontamination of blood and blood products - Google Patents

Ozone decontamination of blood and blood products

Info

Publication number
HK45193A
HK45193A HK451/93A HK45193A HK45193A HK 45193 A HK45193 A HK 45193A HK 451/93 A HK451/93 A HK 451/93A HK 45193 A HK45193 A HK 45193A HK 45193 A HK45193 A HK 45193A
Authority
HK
Hong Kong
Prior art keywords
blood
ozone
blood component
contacting
component
Prior art date
Application number
HK451/93A
Other languages
German (de)
English (en)
French (fr)
Inventor
Yuan Chung Zee
David C. Bolton
Original Assignee
Medizone International, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medizone International, Inc. filed Critical Medizone International, Inc.
Publication of HK45193A publication Critical patent/HK45193A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0094—Gaseous substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • A61L2/202—Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1698—Blood oxygenators with or without heat-exchangers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0216—Ozone
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK451/93A 1985-04-03 1993-05-06 Ozone decontamination of blood and blood products HK45193A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/719,187 US4632980A (en) 1985-04-03 1985-04-03 Ozone decontamination of blood and blood products

Publications (1)

Publication Number Publication Date
HK45193A true HK45193A (en) 1993-05-14

Family

ID=24889094

Family Applications (1)

Application Number Title Priority Date Filing Date
HK451/93A HK45193A (en) 1985-04-03 1993-05-06 Ozone decontamination of blood and blood products

Country Status (8)

Country Link
US (1) US4632980A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0199479B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6221A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE57474T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1269935A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3674941D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK45193A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SG (1) SG17493G (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971760A (en) * 1986-03-10 1990-11-20 University Of Southern California Novel method for disinfecting red blood cells, blood platelets, blood plasma, and optical corneas and sclerae
US5185371A (en) * 1986-03-10 1993-02-09 University Of Southern California Method for disinfecting red blood cells
US5281392A (en) * 1986-03-10 1994-01-25 Rubinstein Alan I Method for disinfecting red blood cells, blood products, and corneas
US5211912A (en) * 1986-08-01 1993-05-18 University Of Southern California Method for disinfecting red blood cells, blood products, and corneas
JPH02500022A (ja) * 1986-08-01 1990-01-11 ルービンスタイン，アラン，アイ 新規な血液処理法
US4944920A (en) * 1986-08-01 1990-07-31 University Of Southern California Novel method to treat blood
FR2603805A1 (fr) * 1986-09-16 1988-03-18 Transfusion Sanguine Assoc Rgl Procede d'inactivation par ozonolyse de micro-organismes contaminants presents dans des materiaux biologiques essentiellement proteiques, les produits obtenus et leurs applications biologiques et analytiques
EP0265548B1 (de) * 1986-10-30 1990-09-12 Kief, Horst, Dr. med. Verfahren zur Herstellung von keimabgetöteten oder in ihrer Virulenz abgeschwächten Substanzen sowie deren Verwendung
US6303152B1 (en) * 1986-10-30 2001-10-16 Horst Kief Process for the production of substances that have been bactericidally treated and/or exhibit immune-modulatory activity, and the use thereof
IL86417A (en) * 1987-05-22 1992-09-06 Armour Pharma Process for the inactivation of pathogens in biological or pharmaceutical material by mixing with aqueous solution containing a sugar(alcohol)and neutral salts as stabilizers
ATE120375T1 (de) * 1988-04-29 1995-04-15 Medizone Int Inc Vorrichtung für die gesteuerte generierung und verabreichung von ozon.
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV
US5126376A (en) * 1988-06-24 1992-06-30 Stephen Herman Method for treating viral infection using topical administration
US5190977A (en) * 1988-06-24 1993-03-02 Stephen Herman Antiviral compositions
US5270344A (en) * 1988-06-24 1993-12-14 Stephen Herman Method of treating a systemic disorder using trioxolane and diperoxide compounds
US5364879A (en) * 1988-06-24 1994-11-15 Cliveden Ltd. Medical uses of trioxolane and diperoxide compounds
US5086076A (en) * 1988-06-24 1992-02-04 Stephen Herman Antiviral pharmaceutical compositions comprising a terpene ozonide
US5260342A (en) * 1988-06-24 1993-11-09 Stephen Herman Method for treating viral infection parenterally
US5093326A (en) * 1989-06-19 1992-03-03 Stephen Herman Repellant compositions
AU637374B2 (en) * 1990-06-04 1993-05-27 Medizone International, Inc. Ozone decontamination of blood and blood products
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis
US5980954A (en) * 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
US6204058B1 (en) 1992-02-07 2001-03-20 Vasogen Ireland Limited Treatment of autoimmune diseases
US6696092B2 (en) 1992-02-07 2004-02-24 Vasogen Ireland Limited Endothelial lining effects and treatment of vasospastic disorders
GB9617611D0 (en) * 1996-08-22 1996-10-02 Vasogen Inc Treatment of autoimmune disease
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
PT680346E (pt) * 1992-02-07 2002-10-31 Vasogen Inc Metodo para aumentar a concentracao de oxido nitrico no sangue
FR2692486A1 (fr) * 1992-06-23 1993-12-24 Abdelmassih Zaki George Procédé et dispositif de stérilisation du sang des malades du SIDA ou d'une autre maladie bactérienne, parasitaire ou virale du sang.
RU95110699A (ru) * 1992-07-31 1996-11-27 Е.Вейнрайт Базиль Устройство для обработки крови, озоновый генератор для производства озона, устройство для контакта газа и жидкости, способ инактивации вируса иммунодефицита человека в белковом материале
FR2694886A1 (fr) * 1992-08-06 1994-02-25 Zaki George Procédé et dispositif pour stériliser le sang des malades du sida, de la malaria ou d'une autre maladie bactérienne, parasitaire ou virale du sang.
DE4340730C2 (de) * 1993-12-01 1995-10-05 Waltraud Kockerols Verbindungssystem für die hyperbare Ozontherapie an einem Patienten
GB9502347D0 (en) * 1995-02-07 1995-03-29 Ca Nat Research Council Method and apparatus for inactivation of viruses in body fluids
US5540898A (en) * 1995-05-26 1996-07-30 Vasogen Inc. Ozone generator with in-line ozone sensor
US5741894A (en) * 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
WO1998009513A1 (en) * 1996-09-06 1998-03-12 Lifetech Corporation Method and apparatus for the sterilization of biological substrates
WO1998015297A1 (en) * 1996-10-09 1998-04-16 Lifetech Corporation Method for the sterilization of biological materials
CA2274461A1 (en) 1996-12-03 1998-06-11 Lisa Marlene Jeffreys Smith Reactive oxygen intermediates containing compounds effective in inducing cell differentiation of malignant cells such as leukemia
US20040022666A1 (en) * 1998-06-30 2004-02-05 Invitrogen Corporation Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby
US6627426B2 (en) 1997-02-14 2003-09-30 Invitrogen Corporation Methods for reducing adventitious agents and toxins and cell culture reagents produced thereby
US20060003447A1 (en) * 2003-12-30 2006-01-05 Richard Fike Dry powder cells and cell culture reagents and methods of production thereof
US6383810B2 (en) * 1997-02-14 2002-05-07 Invitrogen Corporation Dry powder cells and cell culture reagents and methods of production thereof
EP2172227A3 (en) * 1998-06-30 2011-01-19 Life Technologies Corporation Methods for reducing adventitious agents or toxins in a sample and cell culture reagents produced thereby
AU2001261627A1 (en) * 2000-05-24 2001-12-03 Medizone International, Inc. Method and apparatus for ozone decontamination of biological liquids
JP2004521615A (ja) * 2000-11-06 2004-07-22 インヴィトロジェン コーポレーション 乾燥粉末細胞および細胞培養試薬およびその生産の方法
US20030228564A1 (en) * 2001-05-30 2003-12-11 Edrich Richard Alan Nitric oxide in a pathogen inactivation process
WO2003020103A2 (en) * 2001-09-04 2003-03-13 Amit Technology Science & Medicine Ltd. Method of and device for therapeutic illumination of internal organs and tissues
US20030073945A1 (en) * 2001-10-17 2003-04-17 Liang-Kuang Diang Ozone hemodiafiltration device
US20030118473A1 (en) * 2001-11-02 2003-06-26 Sunnen Gerard V. Method and apparatus for ozone decontamination of biological liquids
DK1461420T3 (da) * 2001-11-30 2010-05-17 Life Technologies Corp Cellekulturmedier
US7118852B2 (en) * 2002-04-11 2006-10-10 Throwleigh Technologies, L.L.C. Methods and apparatus for decontaminating fluids
AU2002306757B2 (en) * 2002-04-12 2009-07-02 Throwleigh Technologies, L.L.C. Methods and apparatus for decontaminating fluids
JP3890044B2 (ja) * 2003-02-18 2007-03-07 シャープ株式会社 活性化ガスが抗原性物質を失活させる性能の評価方法、その評価方法の評価試料として用いる処理済抗原性物質の作成装置
ATE518886T1 (de) 2003-06-09 2011-08-15 Redox Reactive Reagents L L C Verfahren zur änderung der bindungsspezifität von plasmaproteinen durch oxidations- reduktionsreaktionen
US20050189302A1 (en) * 2003-07-31 2005-09-01 Latino Joseph S. Viral inactivation using ozone
US20100318014A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of acute ischemic brain stroke with ozone
US20100316727A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of inflammatory disorders with ozone
WO2005018715A1 (en) * 2003-07-31 2005-03-03 Lipidviro Tech Ozone delivery system including gas-fluid contacting devices and methods of use
US7736494B2 (en) * 2003-07-31 2010-06-15 Acquisci, Inc. Ozone delivery system including a variable pitch gas-fluid contact device
US20100316730A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of cardiovascular diseases with ozone
US7615030B2 (en) * 2003-10-06 2009-11-10 Active O, Llc Apparatus and method for administering a therapeutic agent into tissue
US8777889B2 (en) * 2004-06-15 2014-07-15 Ceramatec, Inc. Apparatus and method for administering a therapeutic agent into tissue
US8066659B2 (en) 2004-06-15 2011-11-29 Ceramatec, Inc. Apparatus and method for treating and dispensing a material into tissue
US20060273045A1 (en) * 2005-06-03 2006-12-07 BAGLEY David Method of spinning water and oxygen for producing super-oxygenated and structured water
US8353906B2 (en) * 2005-08-01 2013-01-15 Ceramatec, Inc. Electrochemical probe and method for in situ treatment of a tissue
EP1779891A1 (en) * 2005-10-28 2007-05-02 Abdula Kurkayev Method of activating a photosensitizer
ITMI20131667A1 (it) * 2013-10-09 2015-04-10 Ind Paolo Gobbi Frattini Metodo per pre-trattare le cellule ematiche prima della separazione.
JP2019534033A (ja) * 2016-08-19 2019-11-28 イミュノレス−セラピューティクス，エルエルシー ガス処理供給システム及び方法
WO2018035504A1 (en) 2016-08-19 2018-02-22 Lane Ronald Howard Gas treatment delivery systems and methods
CN111616284B (zh) * 2020-05-06 2025-01-03 荆州市民康生物科技有限公司 一种吸血水蛭饵料的无毒处理及应用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183962A (en) * 1978-01-16 1980-01-15 Exxon Research & Engineering Co. Process for oxygenating blood by the utilization of liquid membranes
NZ203094A (en) * 1982-02-09 1986-04-11 Univ California Vaccines with ozone-treated microorganisms
US4581231A (en) * 1982-06-10 1986-04-08 The United States Of America As Represented By The Secretary Of Health And Human Services Inactivation of viruses containing essential lipids
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
DE3325568A1 (de) * 1983-07-15 1985-01-24 Erwin Sander Elektroapparatebau GmbH, 3162 Uetze Verfahren zur schonenden ozonbehandlung von fluessigkeiten, wie etwa fruchtsaefte, milch, fluessige milchprodukte, wein, oele, fluessige medikamente, blut und oder aehnliche produkte

Also Published As

Publication number Publication date
SG17493G (en) 1993-04-16
EP0199479B1 (en) 1990-10-17
ATE57474T1 (de) 1990-11-15
JPH0471892B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-11-16
EP0199479A2 (en) 1986-10-29
EP0199479A3 (en) 1987-08-26
DE3674941D1 (de) 1990-11-22
US4632980A (en) 1986-12-30
CA1269935A (en) 1990-06-05
US4632980B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-06-26
JPS6221A (ja) 1987-01-06

Similar Documents

Publication Publication Date Title
EP0199479B1 (en) Ozone decontamination of blood and blood products
Wells et al. Inactivation of human immunodeficiency virus type 1 by ozone in vitro
EP0431129B1 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
CA1319611C (en) Purified hemoglobin solutions and method for making same
Horowitz et al. Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri (n‐butyl) phosphate detergent combinations
AU621148B2 (en) Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US20010034055A1 (en) Methods for removal, purification, and concentration of viruses, and methods of therapy based thereupon
EP1161958B1 (en) A method for the inactivation of viruses
US4542016A (en) Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use
JPH11509210A (ja) 血液製剤中の汚染物質を不活性化する方法及び装置
US4199450A (en) Process of separating from an aqueous medium a protein or a morphologically organized unit by liquid exclusion chromatography
KR890006251A (ko) 고-순도의, 바이러스로부터 보호된 생물학적 활성 트랜스페린 제제의 제조방법
Heinrich et al. Clinical evaluation of the hepatitis safety of a β-propiolactone/ultraviolet treated factor IX concentrate (PPSB)
Omar et al. Virus inactivation by pepsin treatment at pH 4 of IgG solutions: factors affecting the rate of virus inactivation
AU637374B2 (en) Ozone decontamination of blood and blood products
Bechtel et al. Virus removal or inactivation in hemoglobin solutions by ultrafiltration or detergent/solvent treatment
CA2308904C (en) Process for the inactivation of viruses
EP0086071B1 (en) Ozone inactivated organisms as vaccines
RU2629866C1 (ru) Способ конечной инактивации патогенных микроорганизмов
US3061518A (en) Method for the filtration of virus fluids
RU2203066C2 (ru) Способ детоксикации организма
JPS63188391A (ja) 細菌破壊に及び／又は免疫調節に有効な物質の製造方法並びにこれを使用する方法
Harris et al. Freedom from transmission of hepatitis-B of gamma-globulin and heat-inactivated plasma protein fraction prepared from contaminated human plasma by fractionation with solid-phase polyelectrolytes
KR20010023277A (ko) 특정의 보호제를 첨가하지 않고 바이러스를 이중-멸균시킨정맥내 주사용 면역글로불린의 제조방법
US20050189302A1 (en) Viral inactivation using ozone

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)